Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
NCT00097526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2012-11-14
Summary
This study is a multicenter, open-label, postmarketing surveillance study. The substudy will collect information on BMD in adolescents and young adults with GHD or Turner syndrome who are completing GH treatment for statural indications.
Conditions
- Dwarfism, Pituitary
- Turner Syndrome
Sponsors & Collaborators
-
Genentech, Inc.
lead INDUSTRY
Principal Investigators
-
Barbara Lippe, M.D. · Genentech, Inc.
Eligibility
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-04-30
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
More Related Trials
-
A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
NCT00097552 ·Status: COMPLETED
-
Growth Hormone Therapy in Osteogenesis Imperfecta
NCT00001305 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
NCT00191165 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
NCT01604161 ·Status: COMPLETED
-
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
NCT00570011 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
NCT00362063 ·Status: UNKNOWN ·Phase: NA
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Prospective Study on Patients Treated With Norditropin®
NCT00960128 ·Status: COMPLETED
-
Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
NCT01502124 ·Status: COMPLETED ·Phase: PHASE3
-
National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin
NCT00097539 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
NCT00156143 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)
NCT00097617 ·Status: COMPLETED
-
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992 ·Status: UNKNOWN ·Phase: NA
-
Skeletal Muscle Effects of GH in Boys
NCT04020913 ·Status: COMPLETED
-
Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
NCT02693522 ·Status: COMPLETED ·Phase: PHASE3
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT02976675 ·Status: UNKNOWN ·Phase: PHASE4
-
Nutrients and Hormones: Effects in Boys With Disordered Growth
NCT00139451 ·Status: COMPLETED ·Phase: PHASE2
-
A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency
NCT02311894 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Use Investigation of Somatropin for GHD-ADULTS.
NCT00601419 ·Status: COMPLETED
-
Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency
NCT01109017 ·Status: COMPLETED
-
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
NCT01435629 ·Status: COMPLETED